Predictors of mortality after acute hip fracture

• Published in: Journal of general internal medicine : JGIM Vol. 11; no. 12; pp. 765 - 767
• Main Authors: NETTLEMAN, M. D, ALSIP, J, SCHRADER, M, SCHULTE, M
• Format: Journal Article
• Language: English
• Published: Heidelberg Springer 01-12-1996
• Subjects: Aged; Aged, 80 and over; Aspirin - therapeutic use; Biological and medical sciences; Comorbidity; Female; Hip Fractures - mortality; Hospital Mortality; Humans; Injuries of the limb. Injuries of the spine; Iowa; Male; Medical sciences; Medicare - statistics & numerical data; Platelet Aggregation Inhibitors - therapeutic use; Postoperative Care; Regression Analysis; Retrospective Studies; Risk Factors; Thrombophlebitis - prevention & control; Traumas. Diseases due to physical agents; United States; United States; Iowa; Human; Postoperative; Statistical analysis; Mortality; Diseases of the osteoarticular system; Cardiopulmonary; Fracture; Acetylsalicylic acid; Hip; Non steroidal antiinflammatory agent; Prevention; Chemotherapy; Health policy; Surgery; Hospital ward; Complication; Salicylates; Predictive factor; Elderly; Resuscitation
• ISSN: 0884-8734; 1525-1497
• DOI: 10.1007/bf02598997

To identify determinants of mortality after hip fracture, we performed a multicenter, retrospective study of 390 Medicare beneficiaries. Independent predictors of 30-day mortality included a history of congestive heart failure (odds ratio [OR] 32; 95% confidence interval [CI] 5, 192), angina (OR 26; 95% CI 4, 184), or chronic pulmonary disease (OR 11; 95% CI 2, 62). Postoperative use of aspirin was associated with a reduced risk of mortality (OR 0.24; 95% CI 0.08, 0.70). Cardiovascular events were the presumed cause of 63% of in-hospital deaths. Aspirin may have significant potential to reduce mortality in this population and deserves further study.